2-Isopropyl-3H-imidazo[4,5-b]pyridine

Catalog No.: 
ACEHYB700
CAS No.: 
21714-53-4
Molecular Formula: 
C9H11N3
Molecular Weight: 
161.21
2-Isopropyl-3H-imidazo[4,5-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$117.00InquiryInquiry
5g95%$422.00InquiryInquiry
25g95%$2068.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Isopropyl-3H-imidazo[4,5-b]pyridine
IUPAC Name2-isopropyl-1H-imidazo[4,5-b]pyridine
Molecular FormulaC9H11N3
Molecular Weight161.21
SMILESCC(C1=NC2=CC=CN=C2N1)C
InChI KeyWUKJJZNDQTZOFB-UHFFFAOYSA-N
Synonym1H-Imidazo[4,5-b]pyridine,2-(1-methylethyl)-(9CI);3H-Imidazo[4,5-b]pyridine, 2-(1-methylethyl)-;2-(Propan-2-yl)-3H-imidazo[4,5-b]pyridine
CAS No.21714-53-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACEHYB700 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACICVF063 route compound structure diagram
    ACICVF06315432-56-1In Stock
  2. Plus
  3. ACJFZC504 route compound structure diagram
    ACJFZC504452-58-4In Stock
  4. Then
  5. ACEHYB700 route product structure diagram
    ACEHYB70021714-53-4
Inquiry

2. ACEHYB700 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJFZC504 route compound structure diagram
    ACJFZC504452-58-4In Stock
  4. Then
  5. ACEHYB700 route product structure diagram
    ACEHYB70021714-53-4
Inquiry

3. ACEHYB700 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEHYB700 route product structure diagram
    ACEHYB70021714-53-4
Inquiry

Comments (0)